Literature DB >> 9670800

Long-term outcome of cognitive therapy's contribution to self-exposure in vivo to the treatment of generalized social phobia.

K Salaberría1, E Echeburúa.   

Abstract

The aim of this work was to test the contribution of cognitive therapy to exposure in vivo in the group treatment of generalized social phobia. Seventy-one severely disabled social phobics, selected according to DSM-III-R criteria, were assigned at random to: (a) self-exposure in vivo, (b) self-exposure in vivo with cognitive therapy, or (c) a waiting-list control group. A multigroup experimental design with repeated measures of assessment (pretreatment, posttreatment, and 1-, 3-, 6-, and 12-month follow-ups) was used. Additionally, half of the patients in both therapeutic groups were given self-help manuals for managing anxiety. Most patients that were treated (64%) showed significant improvement at the 12-month follow-up, but there were no differences between the two therapeutic models. No improvement was shown by the control-group participants at the 6-month follow-up. The results of the present trial do not support the beneficial effects of adding cognitive therapy or a self-help manual to exposure alone. Finally, several topics that may contribute to future research in this field are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9670800     DOI: 10.1177/01454455980223003

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  2 in total

1.  How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence.

Authors:  Pim Cuijpers; Ioana A Cristea; Eirini Karyotaki; Mirjam Reijnders; Marcus J H Huibers
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

Review 2.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.